1. Home
  2. ESCA vs AVXL Comparison

ESCA vs AVXL Comparison

Compare ESCA & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Escalade Incorporated

ESCA

Escalade Incorporated

HOLD

Current Price

$18.84

Market Cap

253.8M

ML Signal

HOLD

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$2.69

Market Cap

251.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESCA
AVXL
Founded
1922
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
253.8M
251.1M
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
ESCA
AVXL
Price
$18.84
$2.69
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$22.00
AVG Volume (30 Days)
38.1K
879.2K
Earning Date
04-30-2026
05-08-2026
Dividend Yield
3.50%
N/A
EPS Growth
6.45
N/A
EPS
0.32
N/A
Revenue
$180,541,000.00
N/A
Revenue This Year
$4.15
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$58.50
N/A
Revenue Growth
2.71
N/A
52 Week Low
$11.41
$2.61
52 Week High
$21.32
$13.99

Technical Indicators

Market Signals
Indicator
ESCA
AVXL
Relative Strength Index (RSI) 51.82 32.27
Support Level $17.25 $2.61
Resistance Level $18.72 $3.50
Average True Range (ATR) 0.91 0.18
MACD -0.11 -0.04
Stochastic Oscillator 28.57 6.39

Price Performance

Historical Comparison
ESCA
AVXL

About ESCA Escalade Incorporated

Escalade Inc manufactures and distributes sporting goods for a varied range of activities. These sports include archery, table tennis, basketball goals, trampoline, play systems, fitness, game tables like hockey and soccer, billiards, darting, and other outdoor games. These products are sold under the brand names like Goalrilla, Goalsetter, Woodplay, Silverback, Nodor, Rage, Child Life, among others. The geographic segments in which the company operates are the United States, Canada, Australia, and Other regions.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: